AANS Neurosurgeon | Volume 27, Number 2, 2018


New Biochip-based Blood Test Detects Elevated Risk for Alzheimer's Disease

Researchers at AACC Annual Scientific Meeting show test performs with same accuracy as gold standard DNA test 

Researcher today unveiled results from a new blood test to help identify which patients are at an elevated risk of Alzheimer’s disease. The findings, presented at the 68th AACC Annual Scientific Meeting & Clinical Lab expo in Philadelphia, showed that the biochip test, which allows multiple tests to be run on one blood sample, was as accurate as existing molecular tests that analyze DNA. “This is the first time that we have used this biochip technology to test for an increased risk of Alzheimer’s disease,” said Emma C. Harte, PhD, a research scientist at Randox Laboratories. “This type of testing is important in our quest to undestand and diagnose Alzheimer’s and empower patients to understand risks, consider medication and even make early lifestyle changes.” To read more, click here.

Comments are closed.